Equilibrative nucleoside transporter

From Wikipedia, the free encyclopedia
Jump to: navigation, search

The equilibrative nucleoside transporter (ENT) family, also known as SLC29, is a group of plasmalemmal transport proteins which transport nucleoside substrates like adenosine into cells.[1] There are four known ENTs, designated ENT1, ENT2, ENT3, and ENT4.[1][2] ENTs are blocked by adenosine reuptake inhibitors like dipyridamole and dilazep, drugs used clinically for their vasodilatory properties.[2][3]

See also[edit]

References[edit]

  1. ^ a b Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, Young JD (February 2004). "The equilibrative nucleoside transporter family, SLC29". Pflügers Archiv : European Journal of Physiology 447 (5): 735–43. doi:10.1007/s00424-003-1103-2. PMID 12838422. 
  2. ^ a b Molina-Arcas M, Casado FJ, Pastor-Anglada M (October 2009). "Nucleoside transporter proteins". Current Vascular Pharmacology 7 (4): 426–34. PMID 19485885. 
  3. ^ Noji T, Karasawa A, Kusaka H (July 2004). "Adenosine uptake inhibitors". European Journal of Pharmacology 495 (1): 1–16. doi:10.1016/j.ejphar.2004.05.003. PMID 15219815. 

Further reading[edit]

  • Molina-Arcas M, Casado FJ, Pastor-Anglada M (October 2009). "Nucleoside Transporter Proteins". Current Vascular Pharmacology 7 (4): 426–34. PMID 19485885. 
  • Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, Young JD (February 2004). "The equilibrative nucleoside transporter family, SLC29". Pflügers Archiv : European Journal of Physiology 447 (5): 735–43. doi:10.1007/s00424-003-1103-2. PMID 12838422. 
  • Molina-Arcas M, Trigueros-Motos L, Casado FJ, Pastor-Anglada M (June 2008). "Physiological and pharmacological roles of nucleoside transporter proteins". Nucleosides, Nucleotides & Nucleic Acids 27 (6): 769–78. doi:10.1080/15257770802145819. PMID 18600539.